EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 20 / No 1 (Janvier 2004) Med Sci (Paris), 20 1 (2004) 98-104 References
Free Access
Issue
Med Sci (Paris)
Volume 20, Number 1, Janvier 2004
Page(s) 98 - 104
Section Dossier technique
DOI https://doi.org/10.1051/medsci/200420198
Published online 15 January 2004
  1. Ruygrok PN, Serruys PW. Intracoronary stenting. From concept to custom. Circulation 1996; 94 : 882–90. [Google Scholar]
  2. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331 : 489–95. [Google Scholar]
  3. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331 : 496–501. [Google Scholar]
  4. Lincoff AM, Califf RM, Moliterno DJ, et al. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of platelet IIb/IIIa inhibition in stenting investigators. N Engl J Med 1999; 341 : 319–27. [Google Scholar]
  5. Eltchaninoff H, Koning R, Tron C, et al. Balloon angioplasty for the treatment of coronary in-stent restenosis : Immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol 1998; 32 : 980–4. [Google Scholar]
  6. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996; 94 : 1247–54. [Google Scholar]
  7. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99 : 44–52. [Google Scholar]
  8. Rogers C, Edelman ER, Simon DI. A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci USA 1998; 95 : 10134–9. [Google Scholar]
  9. Feldman LJ, Aguirre L, Ziol M, et al. Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation 2000; 101 : 908–16. [Google Scholar]
  10. Feldman LJ, Mazighi M, Scheuble A, et al. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation 2001; 103 : 3117–22. [Google Scholar]
  11. The ERASER investigators. Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). Circulation 1999; 100 : 799–806. [Google Scholar]
  12. Meurice T, Bauters C, Hermant X, et al. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS) : A randomised, double-blind, placebo-controlled trial. Lancet 2001; 357 : 1321–4. [Google Scholar]
  13. van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94 : 1690–7. [Google Scholar]
  14. Tamai H, Igaki K, Kyo E, et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000; 102 : 399–404. [Google Scholar]
  15. Yamawaki T, Shimokawa H, Kozai T, et al. Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. J Am Coll Cardiol 1998; 32 : 780–6. [Google Scholar]
  16. Ye YW, Landau C, Willard JE, et al. Bioresorbable microporous stents deliver recombinant adenovirus gene transfer vectors to the arterial wall. Ann Biomed Eng 1998; 26 : 398–408. [Google Scholar]
  17. Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998; 352 : 673–81. [Google Scholar]
  18. Gallo R, Padurean A, Jayaraman T, et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 1999; 99 : 2164–70. [Google Scholar]
  19. Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104 : 1188–93. [Google Scholar]
  20. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries : a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001; 103 : 192–5. [Google Scholar]
  21. Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents : one-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104 : 2007–11. [Google Scholar]
  22. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346 : 1773–80. [Google Scholar]
  23. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349 : 1315–23. [Google Scholar]
  24. Jordan MA, Toso RJ, Thrower D, et al. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 1993; 90 : 9552–6. [Google Scholar]
  25. Sollott SJ, Cheng L, Pauly RR, et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest 1995, 95 : 1869–76. [Google Scholar]
  26. Heldman AW, Cheng L, Jenkins GM, et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 2001; 103 : 2289–95. [Google Scholar]
  27. Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001; 104 : 473–9. [Google Scholar]
  28. Drachman DE, Edelman ER, Seifert P, et al. Neointimal thickening after stent delivery of paclitaxel. Change in composition and arrest of growth over six months. J Am Coll Cardiol 2000; 36 : 2325–32. [Google Scholar]
  29. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108 : 788–94. [Google Scholar]
  30. Klugherz BD, Jones PL, Cui X, et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol 2000; 18 : 1181–4. [Google Scholar]
  31. Goueffic Y, Meddahi A, Mezzina M, Mazighi M, Feldman L. Smooth muscle cell seeding after arterial injury. Eur Heart J 2001; 22 : 429. [Google Scholar]
  32. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis : new perspectives and therapeutic strategies. Nat Med 2002; 8 : 1249–56. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.